Recombinant human Clara cell secretory protein in acute lung injury of the rabbit: Effect of route of administration

Pediatric Critical Care Medicine

Volumn 6, Issue 6, 2005, Pages 698-706

  Miller, Thomas L ^a,b   Shashikant, Beth N ^a   Melby, James M ^c   Pilon, Aprile L ^c   Shaffer, Thomas H ^a,b   Wolfson, Marla R ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c Claragen Incorporated   (United States)

Author keywords

Acute lung injury; Bronchoalveolar lavage; Clara cell secretory protein; Interleukin 8; Lung function; Myeloperoxidase

Indexed keywords

CLARA CELL SECRETORY PROTEIN; INTERLEUKIN 8; MYELOPEROXIDASE; SECRETORY PROTEIN; SURFACTANT; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTICLE; CLARA CELL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; INFLAMMATORY CELL; LUNG FUNCTION; LUNG LAVAGE; LUNG MECHANICS; LYMPHOCYTIC INFILTRATION; NONHUMAN; PATIENT MONITORING; PNEUMONIA; PRIORITY JOURNAL; RABBIT; SAMPLING;

EID: 27844593765     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000165565.96773.08     Document Type: Article

References (58)

1. D'Ortho MP, Jarreau PH, Delacourt C, et al: Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs. Am J Physiol 1994; 266: L209-L216
2. Gibbs DF, Shanley TP, Warner RL, et al: Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury: Evidence for alveolar macrophage as source of proteinases. Am J Respir Cell Mol Biol 1999; 20:1145-1154
3. Lee WL, Downey GP: Leukocyte elastase: Physiological functions and role in acute lung injury. Am J Respir Crit Care Med 2001; 164:896-904
4. Kawabata K, Hagio T, Matsuoka S: The role of neutrophil elastase in acute lung injury. Eur J Pharmacology 2002; 451:1-10
5. Keck T, Balcom JH, Fernandez-del Castillo C, et al: Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 2002; 122:188-201
6. Moraes TJ, Chow CW, Downey GP: Proteases and lung injury. Crit Care Med 2003; 31:S189-S194
7. Moore TM, Khimenko PL, Taylor AE: Endothelial damage caused by ischemia and reperfusion and different ventilatory strategies in the lung. Chin J Physiol 1996; 39:65-81
8. Lee WL, Downey GP: Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001; 7:1-7
9. Ikegami M, Jobe A, Jacobs H, et al: A protein from airways of premature lambs that inhibits surfactant function. J Appl Physiol 1984; 57:1134-1142
10. Ueda T, Ikegami M, Jobe A: Surfactant subtypes: In vitro conversion, in vivo function, and effects of serum proteins. Am J Respir Crit Care Med 1994; 149:1254-1259
11. Holm BA, Notter RH: Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol 1987; 63:1434-1442
12. Davis JM, Rosenfeld WN, Richter SE, et al: Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1997; 100:24-30
13. Chandra S, Davis JM, Drexler S, et al: Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury. Pediatr Res 2003; 54:509-515
14. Levine CR, Gewolb IH, Welch R, et al: Safety, pharmacokinetics and anti-inflammatory activity of rhCC10 in premature infants with respiratory distress syndrome (RDS). Pediatr Res 2005; 58:15-21
15. Davis JM, Rosenfeld WN, Sanders RJ, et al: Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J Appl Physiol 1993; 74:2234-2241
16. Ryerse JS, Hoffmann JW, Mahmoud S, et al: Immunolocalization of CC10 in Clara cells in mouse and human lung. Histochem Cell Biol 2001; 115:325-332
17. Nosratabadi AR, Ljungman AG, Lindahl M, et al: Clara cell 10-KDA protein inhibits endotoxin-induced airway contraction in isolated perfused rat lungs. Exp Lung Res 2003; 29:455-473
18. Vasanthakumar G, Manjunath R, Mukherjee AB, et al: Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection. Biochem Pharmacol 1988; 37:389-394
19. Dierynck I, Bernard A, Roels H, et al: The human Clara cell protein: Biochemical and biological characterisation of a natural immunosuppressor. Mult Scler 1996; 1:385-387
20. Levin SW, Butler JD, Schumacher UK, et al: Uteroglobin inhibits phospholipase A2 activity. Life Sci 1986; 38:1813-1819
21. Duncan JE, Hatch GM, Belik J: Susceptibility of exogenous surfactant to phospholipase A2 degradation. Can J Physiol Pharmacol 1996; 74:957-963
22. Geerts L, Jorens PG, Willems J, et al: Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med 2001; 29:1920-1924
23. Ramsay PL, DeMayo FJ, Hegemier SE, et al: Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 164:155-161
24. Al-Rahmani A, Awad K, Miller TF, et al: Effects of partial liquid ventilation with perfluorodecalin in the juvenile rabbit lung after saline injury. Crit Care Med 2000; 28:1459-1464
25. Miller TF, Milestone B, Stern R, et al: Effects of perfluorochemical distribution and elimination dynamics on cardiopulmonary function. J Appl Physiol 2001; 90:839-849
26. Evander E, Wollmer P, Jonson B, et al: Pulmonary clearance of inhaled 99mTc-DTPA: Effects of surfactant depletion by lung lavage. J Appl Physiol 1987; 62:1611-1614
27. Bhutani VK, Sivieri EM, Abbasi S, et al: Evaluation of neonatal pulmonary mechanics and energetics: A two factor least mean square analysis. Pediatr Pulmonol 1988; 4:150-158
28. Antunes MJ, Cullen JA, Holt WJ, et al: Continued pulmonary recovery observed after discontinuing extracorporeal membrane oxygenation. Pediatr Pulmonol 1994; 17:143-148
29. Khan AM, Shabarek FM, Kutchback JW, et al: Effects of dexamethasone on meconium aspiration syndrome in newborn piglets. Pediatr Res 1999; 46:179-183
30. Notter RH, Egan EA, Kwong MS, et al: Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: Effects of dose, dispersion technique, and gestational age. Pediatr Res 1985; 19:569-577
31. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37:911-917
32. Bartlett GR: Phosphorus assay in column chromatography. J Biol Chem 1959; 234:466-468
33. Rouser G, Fleischer S, Yamamoto A: Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970; 5:494-496
34. Enhorning G: Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977; 43:198-203
35. Zhu G, Shaffer TH, Wolfson MR: Continuous tracheal gas insufflation during partial liquid ventilation in juvenile rabbits with acute lung injury. J Appl Physiol 2003
36. Schierwagen C, Bylund-Fellenius AC, Lundberg C: Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 1990; 23:179-186
37. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254
38. Wolfson MR, Greenspan JS, Deoras KS, et al: Comparison of gas and liquid ventilation: Clinical, physiological, and histological correlates. J Appl Physiol 1992; 72:1024-1031
39. Wolfson MR, Kechner NE, Roache RF, et al: Perfluorochemical rescue after surfactant treatment: Effect of perflubron dose and ventilatory frequency. J Appl Physiol 1998; 84:624-640
40. Deoras KS, Wolfson MR, Searls RL, et al: Use of a touch sensitive screen and computer assisted image analysis for quantitation of developmental changes in pulmonary structure. Pediatr Pulmonol 1990; 9:109-118
41. Damoiseaux JG, Dopp EA, Calame W, et al: Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ed1. Immunology 1994; 83:140-147
42. Dijkstra CD, Dopp EA, Joling P, et al: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54:589-599
43. Peters JH, Ginsberg MH, Case CM, et al: Release of soluble fibronectin containing an extra type III domain (ED1) during acute pulmonary injury mediated by oxidants or leukocytes in vivo. Am Rev Respir Dis 1988; 138:167-174
44. Barbe MF, Barr AE, Gorzelany I, et al: Chronic repetitive reaching and grasping results in decreased motor performance and widespread tissue responses in a rat model of MSD. J Orthop Res 2003; 21:167-176
45. Ito Y, Goffin J, Veldhuizen R, et al: Timing of exogenous surfactant administration in a rabbit model of acute lung injury. J Appl Physiol 1996; 80:1357-1364
46. Ito Y, Manwell SE, Kerr CL, et al: Effects of ventilation strategies on the efficacy of exogenous surfactant therapy in a rabbit model of acute lung injury. Am J Respir Crit Care Med 1998; 157:149-155
47. van Eeden SF, Klut ME, Leal MA, et al: Partial liquid ventilation with perfluorocarbon in acute lung injury: Light and transmission electron microscopy studies. Am J Respir Cell Mol Biol 2000; 22:441-450
48. Imai Y, Nakagawa S, Ito Y, et al: Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation. J Appl Physiol 2001; 91:1836-1844
49. Rotta AT, Gunnarsson B, Fuhrman BP, et al: Comparison of lung protective ventilation strategies in a rabbit model of acute lung injury. Crit Care Med 2001; 29:2176-2184
50. Jeng MJ, Yang SS, Wolfson MR, et al: Perfluorochemical (PFC) combinations for acute lung injury: An in vitro and in vivo study in juvenile rabbits. Pediatr Res 2003; 53:81-88
51. Tutuncu AS, Faithfull NS, Lachmann B: Comparison of ventilatory support with intratracheal perfluorocarbon administration and conventional mechanical ventilation in animals with acute respiratory failure. Am Rev Respir Dis 1993; 148:785-792
52. Abu-Soud HM, Hazen SL: Nitric oxide modulates the catalytic activity of myeloperoxidase. J Biol Chem 2000; 275:5425-5430
53. Rodrigues MR, Rodriguez D, Russo M, et al: Macrophage activation includes high intracellular myeloperoxidase activity. Biochem Biophys Res Commun 2002; 292:869-873
54. Strieter RM, Kunkel SL: Acute lung injury: The role of cytokines in the elicitation of neutrophils. J Investig Med 1994; 42:640-651
55. Bradley PP, Priebat DA, Christensen RD, et al: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78:206-209
56. Niu JO, Munshi UK, Siddiq MM, et al: Early increase in endothelin-1 in tracheal aspirates of preterm infants: Correlation with bronchopulmonary dysplasia. J Pediatr 1998; 132:965-970
57. Kotecha S, Chan B, Azam N, et al: Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1995; 72:F90-F96
58. Kunkel SL, Standiford T, Kasahara K, et al: Interleukin-8 (il-8): The major neutrophil chemotactic factor in the lung. Exp Lung Res 1991; 17:17-23